Literature DB >> 27312931

The Italian Society of Surgical Oncology (SICO) survey on the minimum requirements of rare cancers referral centers.

Alessandro Gronchi1, Paolo Delrio2, Vittorio Quagliuolo3, Sergio Sandrucci4.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27312931     DOI: 10.1007/s13304-016-0376-x

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


× No keyword cloud information.
  4 in total

1.  Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.

Authors: 
Journal:  Epidemiol Prev       Date:  2014 Nov-Dec       Impact factor: 1.901

2.  Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

Authors:  Susanna Busco; Carlotta Buzzoni; Sandra Mallone; Annalisa Trama; Marine Castaing; Francesca Bella; Rosalba Amodio; Sabrina Bizzoco; Tiziana Cassetti; Claudia Cirilli; Rosanna Cusimano; Roberta De Angelis; Mario Fusco; Gemma Gatta; Valerio Gennaro; Adriano Giacomin; Paolo Giorgi Rossi; Lucia Mangone; Salvatore Mannino; Silvia Rossi; Daniela Pierannunzio; Andrea Tavilla; Sandro Tognazzo; Rosario Tumino; Massimo Vicentini; Maria Francesca Vitale; Emanuele Crocetti; Luigino Dal Maso
Journal:  Epidemiol Prev       Date:  2016 Jan-Feb       Impact factor: 1.901

3.  Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.

Authors:  Sandra Mallone; Roberta De Angelis; Jan Maarten van der Zwan; Annalisa Trama; Sabine Siesling; Gemma Gatta; Riccardo Capocaccia
Journal:  Cancer Epidemiol       Date:  2013-09-16       Impact factor: 2.984

4.  The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project.

Authors:  Annalisa Trama; Sandra Mallone; Stefano Ferretti; Francesca Meduri; Riccardo Capocaccia; Gemma Gatta
Journal:  Tumori       Date:  2012 Sep-Oct
  4 in total
  1 in total

1.  Organization of Bone Sarcoma Care: A Cross-Sectional European Study.

Authors:  Louren Matthias Goedhart; Andreas Leithner; Paul Christiaan Jutte
Journal:  Orthop Surg       Date:  2020-06-26       Impact factor: 2.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.